GoMe

Personalized Treatment Platform for Childhood Obesity

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Follow

Company Overview

Snapshot

Founded in September 2019 by Dan Avramov and Ran Gilhar, GoMe operates with 1–10 employees. The company ceased operations in December 2020.

Business overview

GoMe is developing a digitized, one-stop platform for customizing childhood obesity treatments and monitoring patients, including children and their families. The company's core technology is an automated software treatment platform featuring an advanced algorithm that creates personalized therapeutic roadmaps. It provides an advanced dashboard with insights, feedback, recommendations, and alerts. GoMe serves the digital healthcare and digital therapeutics sectors, targeting therapists, parents with support tools, and children through interactive gamification activities, customized videos, and a social media community to inspire habit change.

Log in to access full profile

Company Intelligence Q&A

What is GoMe's primary focus?
GoMe focuses on developing a personalized treatment platform for childhood obesity, aiming to digitize and customize therapeutic approaches for children and their families.
When was GoMe founded?
GoMe was founded in September 2019.
Who are the founders of GoMe?
GoMe was co-founded by Dan Avramov, who serves as CTO, and Ran Gilhar, who holds the roles of COO and CFO.
What is the status of GoMe?
GoMe is currently non-active, having ceased operations in December 2020.
What technology does GoMe utilize?
GoMe utilizes an automated software treatment platform with an advanced algorithm to build personalized therapeutic roadmaps. The system includes a dashboard for insights, feedback, recommendations, and alerts.
Log in to access full profile